{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:22:47Z","timestamp":1792873367291,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>Managing contraception for women at high risk for thrombosis poses unique challenges. Combined estrogen and progestin contraceptives increase the risk of both venous and arterial thrombosis. They are contraindicated in women with a history of thrombosis and in other women at high risk for thrombosis. However, progestin-only contraceptives are generally considered safe in this patient population. This paper reviews the evidence linking hormonal contraception and clotting risk, outlines appropriate contraceptive methods for women at high risk for thrombosis, discusses surgical risk for sterilization in the setting of current or past thrombosis, and includes a review of the safety of hormonal methods for women who are fully anticoagulated. In general, long-acting reversible contraception is safe for women with a history of thrombosis and may offer additional noncontraceptive benefits for women who are on anticoagulant therapy, such as improved bleeding profiles.<\/jats:p>","DOI":"10.1097\/grf.0000000000000356","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T01:19:35Z","timestamp":1520558375000},"page":"243-249","source":"Crossref","is-referenced-by-count":13,"title":["Contraceptive Management for Women Who Are at High Risk of Thrombosis"],"prefix":"10.1097","volume":"61","author":[{"given":"BEVERLY","family":"GRAY","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SERINA","family":"FLOYD","sequence":"additional","affiliation":[{"name":"Planned Parenthood of Metropolitan Washington DC Inc., Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDRA H.","family":"JAMES","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R2-20230911","first-page":"1","article-title":"Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013","volume":"173","author":"Daniels","year":"2015","journal-title":"Natl Health Stat Rep"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11239-006-0003-7","article-title":"Menorrhagia and minor bleeding symptoms in women on oral anticoagulation","volume":"24","author":"Sjalander","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"R4-20230911","first-page":"205","article-title":"Ovarian hemorrhage in ovulating women receiving anticoagulant therapy. A report of two cases","volume":"29","author":"Hill","year":"1984","journal-title":"J Reprod Med"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(61)92891-4","article-title":"Clinical features of pulmonary embolism","volume":"1","author":"Barritt","year":"1961","journal-title":"Lancet"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0031-1297367","article-title":"Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective","volume":"37","author":"Lijfering","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/AOG.0b013e3182839e0e","article-title":"Nonsurgical management of heavy menstrual bleeding: a systematic review","volume":"121","author":"Matteson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.contraception.2009.02.007","article-title":"The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement","volume":"80","author":"Kilic","year":"2009","journal-title":"Contraception"},{"key":"R22-20230911","first-page":"CD006034","article-title":"Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use","author":"Grimes","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20230911","first-page":"1","article-title":"Providing quality family planning services: recommendations of CDC and the US Office of Population Affairs","volume":"63","author":"Gavin","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jmig.2013.06.001","article-title":"Venous thromboembolic events in minimally invasive gynecologic surgery","volume":"20","author":"Ramirez","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201806000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:12:56Z","timestamp":1694419976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201806000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000356","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}